{"disease":{"id":"hsil","name":"hsil"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05282745","title":"A Multicenter Cohort Study of HPV Viral Load in Predicting the Postoperative Recurrence of HSIL","phase":"","overall_status":"UNKNOWN","enrollment_count":4000,"lead_sponsor_name":"Fujian Maternity and Child Health Hospital","has_results":false},{"nct_id":"NCT04190472","title":"Intraoperative HPV Testing Evaluation","phase":"","overall_status":"UNKNOWN","enrollment_count":1553,"lead_sponsor_name":"Hospital Universitari Vall d'Hebron Research Institute","has_results":false},{"nct_id":"NCT06208319","title":"Development and Evaluation of an Artificial Intelligence Tool for Colposcopy Assistance","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT05745597","title":"Prognostic Study of HPV Virus Integration in Women With HSIL","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Fujian Maternity and Child Health Hospital","has_results":false},{"nct_id":"NCT05283239","title":"Research About Impact of HPV Integration on the Prognosis of Women With Persistent HR-HPV Infection","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Fujian Maternity and Child Health Hospital","has_results":false},{"nct_id":"NCT07123558","title":"Anal Cancer Prevention in High-Risk Categories of Men Who Have Sex With Men","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":700,"lead_sponsor_name":"Bispebjerg Hospital","has_results":false},{"nct_id":"NCT06052696","title":"Adjuvant Nonavalent HPV Vaccination in Women Treated for Vulvar HSIL","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Erasmus Medical Center","has_results":false},{"nct_id":"NCT05282095","title":"Effect of HPV Integration on Prognosis of Young Women With CIN2 in China","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Fujian Maternity and Child Health Hospital","has_results":false},{"nct_id":"NCT05120167","title":"Strategies for Endocervical Canal Investigation in Women With Abnormal Screening Cytology and Negative Colposcopy","phase":"NA","overall_status":"COMPLETED","enrollment_count":288,"lead_sponsor_name":"Cirbia Silva Campos Teixeira","has_results":false},{"nct_id":"NCT03721978","title":"REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":203,"lead_sponsor_name":"Inovio Pharmaceuticals","has_results":true},{"nct_id":"NCT03185013","title":"REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":201,"lead_sponsor_name":"Inovio Pharmaceuticals","has_results":true},{"nct_id":"NCT07175662","title":"Evaluation of NWRD08 for HPV-16 and/or HPV-18 Related Cervical HSIL","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Newish Biotech (Wuxi) Co., Ltd.","has_results":false},{"nct_id":"NCT05060640","title":"ANAL PRECANCEROUS LESIONS IN HIGH-RISK PATIENTS.","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"University Fernando Pessoa","has_results":false},{"nct_id":"NCT06356012","title":"Clinical Outcome and Biomarkers for Predicting Immunological Response in Patients Treated with Imiquimod","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":96,"lead_sponsor_name":"Barretos Cancer Hospital","has_results":false},{"nct_id":"NCT07012356","title":"Does Hr-HPV Status Influence the 2011 IFCPC Nomenclature and Swede Score's Capacity to Diagnose Precancerous Lesions?","phase":"","overall_status":"COMPLETED","enrollment_count":95,"lead_sponsor_name":"Necmettin Erbakan University","has_results":false},{"nct_id":"NCT06949800","title":"CASCADE 2002: PROTECT Study, \"PRObiotics to TrEat Anal preCancer Trial","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":90,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT03202992","title":"Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":57,"lead_sponsor_name":"Antiva Biosciences","has_results":false},{"nct_id":"NCT06206564","title":"Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative Participants","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":48,"lead_sponsor_name":"Frantz Viral Therapeutics, LLC","has_results":false},{"nct_id":"NCT03180684","title":"Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Inovio Pharmaceuticals","has_results":true},{"nct_id":"NCT05858021","title":"COrSIcA: Disease Measurement","phase":"","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"David Finch","has_results":false},{"nct_id":"NCT03113942","title":"Study of Pomalidomide in Anal Cancer Precursors","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":26,"lead_sponsor_name":"Kirby Institute","has_results":false},{"nct_id":"NCT03239223","title":"Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Antiva Biosciences","has_results":false},{"nct_id":"NCT05905354","title":"Clinical Study of HPV Therapeutic DNA Vaccine (NWRD08) in Patients With Cervical HPV16 and/or HPV18 Positive","phase":"NA","overall_status":"UNKNOWN","enrollment_count":12,"lead_sponsor_name":"Newish Technology (Beijing) Co., Ltd.","has_results":false},{"nct_id":"NCT06276101","title":"NWRD08 DNA Plasmid for HPV-16 and/or HPV-18 Related Cervical HSIL","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":9,"lead_sponsor_name":"Newish Technology (Beijing) Co., Ltd.","has_results":false},{"nct_id":"NCT07047989","title":"NWRD09 for HPV-16 Related Cervical HSIL","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":9,"lead_sponsor_name":"Newish Biotech (Wuxi) Co., Ltd.","has_results":false},{"nct_id":"NCT03697226","title":"Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection.","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"Antiva Biosciences","has_results":false},{"nct_id":"NCT03677960","title":"Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":6,"lead_sponsor_name":"Antiva Biosciences","has_results":false},{"nct_id":"NCT03937791","title":"Immunotherapy With E7 T Cell Receptor T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true}],"total":28},"guidelines":[],"source":"Drug Landscape verified database"}